as the company s President and CEO, bringing more than 16 years of knowledge and experience in drug development and bringing products to market. Previously, Mr. Noyes was Chief... Operating Officer of Trine Pharmaceuticals, where he held broad general management responsibility across all functional areas relating to drug development, including preclinical, clinical..., manufacturing, regulatory, marketing and business development. Prior to joining Trine in 2002, Mr. Noyes held several management and leadership roles with GelTex Pharmaceuticals...

., announced today it has received Food and Drug Administration (FDA) fast track designation for the development program for PRT-201 Download article (pdf) March 12 , 2008 Proteon... Therapeutics adds experienced research and drug development talent to its team Download article (pdf) August 28, 2006 EDC of Kansas City announces creation of Kansas City Biotechnology... development program Download article (pdf) July 23, 2004 Proteon Therapeutics, LLC announces award of STTR grant Download article (pdf) June 22, 2004 Proteon Therapeutics, LLC...

developed a method of degrading elastin fibers in treated segments, while leaving the collagen fibers intact and preserving structural integrity. Non-clinical studies by Proteon suggest... in a variety of surgical and endovascular procedures to improve the patency of treated vessels. Clinical Development Programs Proteon Therapeutics is currently pursuing clinical... development programs for PRT-201 in two hemodialysis vascular access indications (arteriovenous fistulas and arteriovenous grafts) and one peripheral artery disease indication. Vascular...

held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with renal and vascular diseases. Proteon Therapeutics first...